MAIA Biotechnology, Inc.
MAIA •
Sell Open
Signal type
Sell
Status
Open
Open Price
$1.38
Stop Loss
$1.78
Performance
0.72%
Days Open
37
Signal Setup
Signal Type Sell
Status Open
Open Date Mar 9, 2026
Open Price $1.38
Stop Loss $1.78
Timespan Day
Company Profile
Name MAIA Biotechnology, Inc.
Ticker MAIA
Market Cap $55.39M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $1.37
List Date Jul 28, 2022
Description
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
Website Open Company Website